how long have glp 1 been around GLP-1 medications were first introduced to regulate diabetes, but recently the conversation these medications has centered around its accessibility and impact on body image GLP-1 drugs: a promising new

Preclinical studies have identified that GLP-1 analogs such as exendin-4 and GLP-1RAs have direct anti-atherosclerotic and anti-inflammatory effects that may contribute to their cardio- and neuroprotective nature.[42] GLP-1RAs can also directly interact with cardiomyocytes, inducing receptor-mediated ischemic conditioning that decreases myocardial infarct size in test animals receiving GLP-1RAs.[43] Similar effects were noted in rodent brains, with liraglutide reducing cerebral infarct volume in rats.[42] Randomized clinical trials (RCTs) also identified that exenatide similarly reduced myocardial infarct size and liraglutide reduced the resulting necrotic area in human patients following a MI.[43] This may account for the reduced need for coronary revascularization in patients on GLP-1RAs.[12] Despite the findings of overall improvements to composite cardiovascular outcomes, GLP-1RAs showed a non-significant trend toward reducing MI risk and did not affect rates of hospitalization for unstable angina in patients with diabetes.[12] These agents tend to have a stronger effect on stroke reduction in such patients, highlighting the complexity and variability of cardiovascular disease and its sequelae

As-needed administration is recommended only for those experienced with Calocurb CLINICAL and knowledgeable of their individual response

preventive services task force

In 2014, Novos Saxenda (liraglutide) became the first GLP-1 agonist approved for obesity

The syringe should be marked "U-100" or "100 units/mL." If your syringe delivery device has different markings, do not use it

Host: Derek Thompson Guest: David Ricks Producer: Devon Baroldi More Plain English Episodes on GLP-1s